China Pharma Holdings Inc (CPHI)’s latest quarter sales figures and margins explained

A share price of China Pharma Holdings Inc [CPHI] is currently trading at $0.25, up 20.67%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The CPHI shares have gain 16.20% over the last week, with a monthly amount glided 37.53%, and seem to be holding up well over a long-time horizon.

From an analyst’s perspective:

China Pharma Holdings Inc [AMEX: CPHI] stock has seen the most recent analyst activity on January 08, 2010, when Rodman & Renshaw initiated its Mkt Outperform rating and assigned the stock a price target of $6.

China Pharma Holdings Inc experienced fluctuations in its stock price throughout the past year between $0.13 and $0.49. China Pharma Holdings Inc [AMEX: CPHI] shares were valued at $0.25 at the most recent close of the market.

Analyzing the CPHI fundamentals

Trailing Twelve Months sales for China Pharma Holdings Inc [AMEX:CPHI] were 5.54M which represents -39.00% decline. Gross Profit Margin for this corporation currently stands at -0.37% with Operating Profit Margin at -0.83%, Pretax Profit Margin comes in at -0.86%, and Net Profit Margin reading is -0.86%. To continue investigating profitability, this company’s Return on Assets is posted at -0.35, Equity is -0.64 and Total Capital is -0.53. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.61.

Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.2143 points at the first support level, and at 0.1775 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.2789, and for the 2nd resistance point, it is at 0.3067.

Ratios To Look Out For

To put it in perspective, the Current Ratio for China Pharma Holdings Inc [AMEX:CPHI] is 0.79. As well, the Quick Ratio is 0.26, while the Cash Ratio is 0.15. Considering the valuation of this stock, the price to sales ratio is 0.87, the price to book ratio is 0.69.

Related Posts